Gross Margin
-5.60%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -10.41%.Updated Sep 20, 2026Profit Margin
-35.47%vs Specialty Chemicals peers Updated Sep 20, 2026Operating Margin
-15.13%vs Specialty Chemicals peers Updated Sep 20, 2026Return on Assets (TTM)
-3.51%vs Specialty Chemicals peers Updated Sep 20, 2026Return on Equity (TTM)
-20.71%vs Specialty Chemicals peers Updated Sep 20, 2026Revenue (TTM)
13.84BTWD435.21M · vs all stocks (USD) Updated Sep 20, 2026Revenue per Share (TTM)
14.27TWDUpdated Sep 20, 2026Quarterly Revenue Growth
-20.20%vs Specialty Chemicals peers Updated Sep 20, 2026Gross Profit (TTM)
-1.44BTWD-45.29M · vs all stocks (USD) Updated Sep 20, 2026EBITDA (TTM)
-1.58BTWD-49.65M · vs all stocks (USD) Updated Sep 20, 2026Net Income (TTM)
-4.88BTWD-153.54M · vs all stocks (USD) Updated Sep 20, 2026Quarterly Earnings Growth (YoY)
-20.17%vs Specialty Chemicals peers Updated Sep 20, 2026Operating Cash Flow (TTM)
1.24BTWD39.07M · vs all stocks (USD) Updated Sep 20, 2026Levered Free Cash Flow (TTM)
-1.29BTWD-40.58M · vs all stocks (USD) Updated Sep 20, 20265-Year Average Dividend Yield
1.76%Updated Sep 20, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Sep 20, 2026Minority Interest (Equity)
1.38BTWDFY2025 · Dec 31, 2025Revenue
15.33BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
16.13BTWDFY2025 · Dec 31, 2025Gross Profit
-800.19MTWDFY2025 · Dec 31, 2025Operating Income
-2.20BTWD-69.15M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-4.43BTWDFY2025 · Dec 31, 2025Income Tax Expense
-4.92MTWDFY2025 · Dec 31, 2025Net Income
-4.52BTWDFY2025 · Dec 31, 2025EBIT
-3.73BTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-2.25BTWDFY2025 · Dec 31, 2025Research & Development
164.14MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
1.23BTWDFY2025 · Dec 31, 2025Non-operating Interest Income
381.29MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
706.93MTWDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-4.52BTWDFY2025 · Dec 31, 2025Minority Interests (P&L)
370.90MTWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
-3.29BTWDFY2025 · Dec 31, 2025Free Cash Flow
-4.36BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
10.59BTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-4.52BTWDFY2025 · Dec 31, 2025Stock-based Compensation
-2.13MTWDFY2025 · Dec 31, 2025Other Non-cash Items
327.95MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
819.54MTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
89.23MTWDFY2025 · Dec 31, 2025Capital Expenditures
-1.07BTWDFY2025 · Dec 31, 2025Net Acquisitions
53.45MTWDFY2025 · Dec 31, 2025Purchase of Investments
0.00TWDFY2025 · Dec 31, 2025Sale of Investments
1.70BTWDFY2025 · Dec 31, 2025Other Investing Activity
-242.90MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
445.67MTWDFY2025 · Dec 31, 2025Long-term Debt Issuance
1.50BTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.77BTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
2.81BTWDFY2025 · Dec 31, 2025Other Financing Charges
13.46MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
2.56BTWDFY2025 · Dec 31, 2025